Park Avenue Securities LLC Eli Lilly & CO Transaction History

Park Avenue Securities LLC

$9.72 Billion
Q4 2024

A detailed history of Park Avenue Securities LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Park Avenue Securities LLC holds 19,274 shares of LLY stock, worth $16.5 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

19,274

Previous 16,893 14.09%

Holding current value

$16.5 Million

Previous $15 Million 0.57%

% of portfolio

0.15%

Previous 0.17%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	BUY	$727.2 - $932.06 $1.73 Million - $2.22 Million	2,381 Added 14.09%	19,274 $14.9 Million
Q3 2024 Oct 03, 2024	SELL	$772.14 - $960.02 $1.32 Million - $1.64 Million	-1,705 Reduced 9.17%	16,893 $15 Million
Q2 2024 Jul 09, 2024	BUY	$724.87 - $909.04 $1.02 Million - $1.28 Million	1,404 Added 8.17%	18,598 $16.8 Million
Q1 2024 Apr 10, 2024	BUY	$592.2 - $792.28 $1.18 Million - $1.57 Million	1,985 Added 13.05%	17,194 $13.4 Million
Q4 2023 Jan 10, 2024	BUY	$525.19 - $619.13 $152,830 - $180,166	291 Added 1.95%	15,209 $8.87 Million
Q3 2023 Oct 26, 2023	SELL	$434.7 - $599.3 $703,344 - $969,667	-1,618 Reduced 9.78%	14,918 $8.01 Million
Q2 2023 Jul 14, 2023	BUY	$350.74 - $468.98 $404,052 - $540,264	1,152 Added 7.49%	16,536 $7.76 Million
Q1 2023 Apr 18, 2023	BUY	$310.63 - $364.82 $1.13 Million - $1.32 Million	3,623 Added 30.81%	15,384 $5.28 Million
Q4 2022 Jan 24, 2023	BUY	$321.55 - $374.67 $277,819 - $323,714	864 Added 7.93%	11,761 $0
Q3 2022 Nov 01, 2022	BUY	$296.48 - $337.87 $412,107 - $469,639	1,390 Added 14.62%	10,897 $3.52 Million
Q2 2022 Jul 27, 2022	BUY	$278.73 - $327.27 $534,325 - $627,376	1,917 Added 25.26%	9,507 $3.08 Million
Q1 2022 Apr 29, 2022	BUY	$234.69 - $291.66 $239,383 - $297,493	1,020 Added 15.53%	7,590 $2.17 Million
Q4 2021 Apr 08, 2022	BUY	$224.85 - $279.04 $213,157 - $264,529	948 Added 16.86%	6,570 $1.81 Million
Q3 2021 Oct 21, 2021	BUY	$221.6 - $272.71 $87,310 - $107,447	394 Added 7.54%	5,622 $1.3 Million
Q2 2021 Aug 05, 2021	BUY	$180.55 - $233.54 $28,707 - $37,132	159 Added 3.14%	5,228 $1.2 Million
Q1 2021 Apr 28, 2021	SELL	$164.32 - $212.72 $3,615 - $4,679	-22 Reduced 0.43%	5,069 $947,000
Q4 2020 Jan 20, 2021	BUY	$130.46 - $172.63 $7,175 - $9,494	55 Added 1.09%	5,091 $860,000
Q3 2020 Nov 03, 2020	BUY	$146.22 - $169.13 $8,626 - $9,978	59 Added 1.19%	5,036 $745,000
Q2 2020 Jul 30, 2020	BUY	$136.42 - $164.18 $678,962 - $817,123	4,977 New	4,977 $817,000
Q1 2020 Apr 28, 2020	SELL	$119.05 - $147.35 $579,892 - $717,741	-4,871 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$106.92 - $132.43 $12,509 - $15,494	117 Added 2.46%	4,871 $640,000
Q3 2019 Oct 18, 2019	BUY	$106.79 - $116.16 $507,679 - $552,224	4,754 New	4,754 $532,000
Q2 2019 Jul 26, 2019	SELL	$110.79 - $129.32 $376,686 - $439,688	-3,400 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$111.31 - $131.02 $378,454 - $445,468	3,400 New	3,400 $439,000

Others Institutions Holding LLY

# of Institutions

4,242

Shares Held

756M

Call Options Held

10.2M

Put Options Held

11.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $814B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Avenue Securities LLC with notifications on news.

Account

Park Avenue Securities LLC Eli Lilly & CO Transaction History